Table 1 Clinicopathological features of fibulin-1 expression in 139 NMIBC patients
From: Fibulin-1 is epigenetically down-regulated and related with bladder cancer recurrence
| Characteristic | Total (n = 139) | Fibulin-1 expression | P-value | ||
|---|---|---|---|---|---|
| Negative (75) | Weak (49) | Strong (15) | |||
| Sex | 0.909 | ||||
| Men | 102 | 54 (52.9%) | 37 (36.3%) | 11 (10.8%) | |
| Women | 37 | 21 (56.8%) | 12 (32.4%) | 4 (10.8%) | |
| Age (years) | 0.657 | ||||
| <average(62) | 64 | 32 (50.0%) | 24 (37.5%) | 8 (12.5%) | |
| ≥average(62) | 75 | 43 (57.3%) | 25 (33.3%) | 7 (9.4%) | |
| Grade | <0.01* | ||||
| Low grade | 91 | 40 (44.0%) | 37 (40.7%) | 14 (15.4%) | |
| High grade | 48 | 35 (72.9%) | 12 (25.0%) | 1 (2.1%) | |
| Stage | 0.225 | ||||
| PTa | 63 | 36 (57.1%) | 18 (28.6%) | 9 (14.3%) | |
| PT1 | 76 | 39 (51.3%) | 31 (40.8%) | 6 (7.9%) | |
